Ketamine Recruiting Phase N/A Trials for Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02573714Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises